SEC Form 4 · accession 0001437749-17-017164
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Oct 12, 2017
Accepted (ET)
Oct 16, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 12, 2017 | G | 120,637 | $0.00 | D | 22,139,012 | I | Shares owned indirectly by Reporting Person through a wholly owned corporation. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Gift of shares to individuals, no consideration received in return.